ONWRF
Price
$5.45
Change
+$0.21 (+4.01%)
Updated
Jul 2 closing price
Capitalization
240.95M
VIR
Price
$5.25
Change
-$0.17 (-3.14%)
Updated
Jul 7, 02:49 PM (EDT)
Capitalization
747.87M
24 days until earnings call
Interact to see
Advertisement

ONWRF vs VIR

Header iconONWRF vs VIR Comparison
Open Charts ONWRF vs VIRBanner chart's image
Onward Med
Price$5.45
Change+$0.21 (+4.01%)
Volume$1.86K
Capitalization240.95M
Vir Biotechnology
Price$5.25
Change-$0.17 (-3.14%)
Volume$380
Capitalization747.87M
ONWRF vs VIR Comparison Chart in %
Loading...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONWRF vs. VIR commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONWRF is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ONWRF: $5.45 vs. VIR: $5.41)
Brand notoriety: ONWRF and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONWRF: 159% vs. VIR: 32%
Market capitalization -- ONWRF: $240.95M vs. VIR: $747.87M
ONWRF [@Biotechnology] is valued at $240.95M. VIR’s [@Biotechnology] market capitalization is $747.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONWRF’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • ONWRF’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONWRF’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • ONWRF’s TA Score: 5 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VIR is a better buy in the short-term than ONWRF.

Price Growth

ONWRF (@Biotechnology) experienced а +19.81% price change this week, while VIR (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.51%. For the same industry, the average monthly price growth was +14.00%, and the average quarterly price growth was -0.49%.

Reported Earning Dates

VIR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($748M) has a higher market cap than ONWRF($241M). ONWRF YTD gains are higher at: -9.147 vs. VIR (-26.294).
ONWRFVIRONWRF / VIR
Capitalization241M748M32%
EBITDAN/A-598.69M-
Gain YTD-9.147-26.29435%
P/E RatioN/AN/A-
RevenueN/A14.3M-
Total CashN/A802M-
Total DebtN/A96.1M-
TECHNICAL ANALYSIS
Technical Analysis
ONWRFVIR
RSI
ODDS (%)
Bearish Trend 5 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
33%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
31%
Bullish Trend 5 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
33%
Bullish Trend 5 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
41%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
50%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
50%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
59%
Bullish Trend 5 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGWCX35.550.40
+1.14%
Virtus Silvant Focused Growth C
PRJQX47.940.46
+0.97%
PGIM Jennison Global Opportunities R6
LSVQX18.880.10
+0.53%
LSV Small Cap Value Institutional
SVXFX65.040.15
+0.23%
Smead International Value I1
NSFHX12.810.02
+0.16%
Natixis Target Retirement 2040 N

ONWRF and

Correlation & Price change

A.I.dvisor tells us that ONWRF and MRVI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONWRF and MRVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
MRVI - ONWRF
30%
Poorly correlated
+0.75%
VIR - ONWRF
30%
Poorly correlated
-0.37%
AGIO - ONWRF
23%
Poorly correlated
+2.04%
ACUT - ONWRF
9%
Poorly correlated
N/A
HLVX - ONWRF
3%
Poorly correlated
N/A
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-0.37%
SANA - VIR
64%
Loosely correlated
+9.25%
CPRX - VIR
44%
Loosely correlated
+0.05%
GOSS - VIR
41%
Loosely correlated
+2.48%
NRIX - VIR
40%
Loosely correlated
+2.33%
HALO - VIR
40%
Loosely correlated
+0.30%
More